Stallergenes Greer, a biopharmaceutical company specialising in allergen immunotherapy (AIT), announces that the European Commission (EC) has approved the extension of indication of Palforzia® ...
The U.S. FDA has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea.
Zacks.com on MSN2d
RARE's Cholesterol Drug Evkeeza Gains EC Approval for Expanded UseUltragenyx Pharmaceutical RARE announced that the European Commission (EC) has expanded the eligible patient population for ...
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...
The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...
By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...
Tryngolza (olezarsen) has been approved by the U.S. Food and Drug Administration as an adjunct to diet to reduce trigl ...
The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals) ...
Victoria Beckham and Anushka Sharma follow a monotrophic diet, and we asked experts for their take on this celebrity-approved trend Victoria Beckham recently shared in an interview with the UK ...
The Food and Drug Administration (FDA) has approved Liraglutide Injection ... It is indicated for use as an adjunct to diet and exercise to improve glycemic control in adults and pediatric ...
The United States Food and Drug Administration (FDA) has approved the weight-loss drug Tirzepatide — sold by the brand name ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback